NCT06780501

Brief Summary

This study consists of two parts: Part One: De-identified Database The goal of this part is to establish a research database containing de-identified data about People with Intellectual Disabilities (PwID) and epilepsy, collected from three NHS sites across England and Wales. Researchers will gather information from participants' medical records, including clinical details, epilepsy history, and medications, and will enter this data into a secure database where all identifying details are removed. This part of the study aims to determine whether it's possible to identify eligible participants, collect complete datasets for each participant, and identify any issues that may affect the quantity and quality of data. These findings will help inform a potential future study that could involve 20 or more sites. Part Two: Research Register The goal of this part is to create a research register of individuals with PwID and epilepsy. Participants will be approached and asked for their consent to collect their personal and clinical data, which will help identify those willing to take part in future ethically approved research projects. As in Part One, researchers will collect data from medical records. Participants who consent to be included in the register may be contacted by external researchers for future studies. The aim is to facilitate national collaboration by enabling data sharing between research projects, thereby improving the ability to answer more questions and enhance patient care. This part of the study will test whether it's possible to determine screening and recruitment rates at each site, develop and evaluate recruitment processes, and assess how researchers leading other approved studies can obtain permission to use the register. Additionally, it will evaluate whether it's possible to collect a complete dataset for each participant.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2024

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 12, 2024

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

September 19, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 17, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2025

Completed
Last Updated

January 17, 2025

Status Verified

September 1, 2024

Enrollment Period

9 months

First QC Date

September 19, 2024

Last Update Submit

January 16, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • The set up of a research database consisting of de-identified data focused on People with Intellectual Disabilities (PwID) and epilepsy at three UK NHS sites across England and Wales.

    De-identified database

    End of study (May 2025)

  • The development of a research register of PwID and epilepsy. Participants will consent to the collection of their personal/clinical data, which will enable the identification of patients willing to take part in other ethically approved research projects.

    Research register

    End of study (May 2025)

Secondary Outcomes (7)

  • Numbers of eligible patients identified at each site for data collection (De-identified database).

    End of study (May 2025)

  • Completeness of clinical data collected (De-identified database)

    End of study (May 2025)

  • Feedback collected from sites about any issues around identifying patients and locating the data required (De-identified database).

    End of study (May 2025)

  • Screening and recruitment rates at each site (Research register).

    End of study (May 2025)

  • Successful recruitment process in place at each site (Research register).

    End of study (May 2025)

  • +2 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adults with a clinical diagnosis of an Intellectual Disability (ID) and epilepsy at participating sites.

You may qualify if:

  • Clinical diagnosis of ID in medical records.
  • Clinical diagnosis of epilepsy in medical records.
  • Patient is over the age of 18 years old.
  • Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts.

You may not qualify if:

  • Other neurodevelopmental disorders without ID.
  • Patient is recorded on the National Data Opt-out as not wishing their data to be used for research/audit.
  • The research register:
  • Clinical diagnosis of ID in medical records.
  • Clinical diagnosis of epilepsy in medical records.
  • Under the current care of specialist ID or epilepsy services at one of the three participating NHS Trusts.
  • Between the ages of 18 and 30 at the time of consent.
  • Participant has the capacity to be able to provide consent for themselves, or a personal consultee is able to provide an opinion on the views and feelings of the potential participant.
  • Patients (or personal consultee) must be able to communicate in English (or Welsh in Welsh site).
  • \- Other neurodevelopmental disorders without ID.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Cornwall Partnership NHS Foundation Trust

Bodmin, United Kingdom

RECRUITING

Royal Free London Hospitals NHS Trust

London, United Kingdom

NOT YET RECRUITING

Swansea Bay University Health Board

Swansea, United Kingdom

RECRUITING

Related Publications (1)

  • Musicha C, Neilens H, Stanyard E, Allgar V, Lomax J, Ashford R, Hambly H, Aspinall P, O'Shaughnessy E, Rollinson C, Lennard S, Mclean B, Simpson A, Bowman P, Angus-Leppan H, Watkins L, Laugharne R, Allard J, Shankar R. Neuropsychiatric research databases for people with intellectual disabilities and epilepsy (REFINE): a feasibility study protocol. BMJ Open. 2025 Nov 26;15(11):e108869. doi: 10.1136/bmjopen-2025-108869.

MeSH Terms

Conditions

EpilepsyIntellectual DisabilityLearning Disabilities

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurobehavioral ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsNeurodevelopmental DisordersMental DisordersCommunication Disorders

Study Officials

  • Lance Watkins

    Swansea Bay University Health Board

    PRINCIPAL INVESTIGATOR
  • Sarah Lennard

    Cornwall Partnership NHS Foundation Trust

    PRINCIPAL INVESTIGATOR
  • Heather Angus-Leppan

    Royal Free London NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor in Neuropsychiatry

Study Record Dates

First Submitted

September 19, 2024

First Posted

January 17, 2025

Study Start

September 12, 2024

Primary Completion

May 31, 2025

Study Completion

May 31, 2025

Last Updated

January 17, 2025

Record last verified: 2024-09

Locations